Clearbridge Health (SGX:1H3) received a listing and quotation notice from the SGX for the listing and quotation of up to 1,279,125,560 rights shares, according to a filing with the Singapore Exchange on Monday.
The medical services company had earlier proposed a rights issue at an issue price of SG$0.002 per rights share.
Proceeds from the issuance worth between SG$515,000 and SG$2.3 million will be used for general working capital needs.
Price (SGD): S$18567.19, Change: S$+49, Percent Change: +0.26%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments